Legal and Privacy Disclosures

Forward-Looking Statements

This website contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "anticipates," "believes," "expects," "intends," "may," "plan," "potential," "projects," "will," and similar expressions. These statements are based on Lyora Therapeutic’s current expectations and involve significant risks and uncertainties that could cause actual results to differ materially from those estimated, including the uncertainties inherent in clinical trials, the timing and outcome of regulatory submissions, and the availability of capital. [Company Name] undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Notice Regarding Securities

This website is intended solely for informational purposes and does not constitute an offer to sell or the solicitation of an offer to buy any securities of Lyora Therapeutics. Any such offer or solicitation will be made only by means of a confidential Private Placement Memorandum and related subscription documents. This website has not been reviewed or approved by the U.S. Securities and Exchange Commission or any state or foreign securities regulator. Access to information regarding any potential investment is restricted to individuals with whom Lyora Therapeutics has a pre-existing substantive relationship and who qualify as "accredited investors" as defined in Rule 501 of Regulation D.

‍